Cargando…

Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma

PURPOSE: To investigate the effects of soluble FGL2 (sFGL2) secreted by hepatic stellate cells (HSCs) on immune suppression in cirrhotic patients with hepatocellular carcinoma (HCC). METHODS: Serum sFGL2 levels were examined by ELISA in 40 patients with HCC, liver cirrhosis (LC) or chronic HBV (CHB)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ying, Xi, Dong, Ding, Wen, Wang, Faxi, Zhou, Haili, Ning, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182595/ https://www.ncbi.nlm.nih.gov/pubmed/25298849 http://dx.doi.org/10.1007/s12072-014-9568-y

Ejemplares similares

Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma
por: Ma, Ya-Nan, et al.
Publicado: (2021)

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
por: Shalev, Itay, et al.
Publicado: (2010)

Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
por: Quiroz Reyes, Adriana G., et al.
Publicado: (2023)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

FGL2–MCOLN3-Autophagy Axis–Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis
por: Li, Xitang, et al.
Publicado: (2022)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

sFgl2 gene-modified MSCs regulate the differentiation of CD4(+) T cells in the treatment of autoimmune hepatitis
por: Ji, Wenbin, et al.
Publicado: (2023)

The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma
por: ZHAO, WENXIU, et al.
Publicado: (2012)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver
por: MA, TIANYOU, et al.
Publicado: (2015)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Identification of the Receptor for FGL2 and Implications for Susceptibility to Mouse Hepatitis Virus (MHV-3)-Induced Fulminant Hepatitis
por: Liu, Hao, et al.
Publicado: (2006)

Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020)

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
por: Liu, Yan, et al.
Publicado: (2017)

Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells
por: WANG, ZHI-MING, et al.
Publicado: (2014)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma
por: Yang, Qiqi, et al.
Publicado: (2017)

Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice
por: Kang, Min-Jung, et al.
Publicado: (2021)

Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4(+) CD25(+) Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice
por: Wang, Junhua, et al.
Publicado: (2015)

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
por: NAGAHARA, TERUYA, et al.
Publicado: (2015)

Hepatic stellate and endothelial cells maintain hematopoietic stem cells in the developing liver
por: Lee, Yeojin, et al.
Publicado: (2020)

Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients
por: Shi, Jijing, et al.
Publicado: (2017)

The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction
por: Huang, Wei-Jian, et al.
Publicado: (2021)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?
por: Herrmann, Jens, et al.
Publicado: (2007)

Soluble egg antigen of Schistosoma japonicum induces pyroptosis in hepatic stellate cells by modulating ROS production
por: Kong, De-Long, et al.
Publicado: (2019)

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
por: Pastore, Mirella, et al.
Publicado: (2022)

The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells
por: Enguita, Mónica, et al.
Publicado: (2019)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma
por: Zhu, Bing, et al.
Publicado: (2015)

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
por: Yu, Guofeng, et al.
Publicado: (2013)

Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
por: Mogler, Carolin, et al.
Publicado: (2017)

PPAR Gamma and Hepatic Stellate Cells
por: Hazra, Saswati, et al.
Publicado: (2004)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma
por: Zhou, Yuan, et al.
Publicado: (2023)

FGL-GAN: Global-Local Mask Generative Adversarial Network for Flame Image Composition
por: Qin, Kui, et al.
Publicado: (2022)

Increased peripheral and local soluble FGL2 in the recovery of renal ischemia reperfusion injury in a porcine kidney auto-transplantation model
por: Zhao, Zitong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6scn7k36rnqcdhonqak4nasits